July 6, 2010

New Potential TB Drugs to be Investigated Against Multiple Neglected Diseases

A Unique Collaboration: TB Alliance and DNDi Enter Cross-Disease License Agreement to Speed Development of Novel Therapies
May 18, 2010

Lancet Article Highlights Hope in the Tuberculosis Drug Development Pipeline

TB Alliance author underscores challenges in TB drug research and development
May 2, 2010

TB Alliance and AstraZeneca Form Research Collaboration to Fight Tuberculosis

New research to speed TB drugs to those who need it most
April 28, 2010

TB Alliance Appoints Robert C. Lorette Senior Vice President, Business Development

Experienced Executive to Play Integral Role in Growing History’s Largest TB Drug Portfolio